NCT01114256|Terminated
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · Stanford University
observational
83
1 country
1
Study Start
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2016
Actual (reported)Study Completion
January 2016
Actual (reported)The purpose of this study is to better understand the biology of the body's immune response to monoclonal antibody therapy for cancer. Your health information will be used to identify your tissues. The tissue we obtain may be useful for research or education, resulting in new drugs, therapies or diagnostic procedures.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
April 23, 2010
Actual (reported)May 3, 2010
Actual (reported)January 2016
Actual (reported)January 2016
Actual (reported)evaluation of change in CD137 positive NK cells in blood & tumors in response to therapeutic moAbs
12 months
Evaluation of activation status of CD137 positive NK cells
12 months
Fine needle aspiration biopsies (FNA) will be performed prior to and 0 to 336 hours after the therapeutic monoclonal antibody infusion.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients at Stanford Cancer Center with lymphoma, squamous cell carcinoma of the head and neck, HER2+ breast adenocarcinoma, colorectal adenocarcinoma, or other solid tumor.
Stanford University School of Medicine
Stanford, California, 94305, United States
Makkouk A, Sundaram V, Chester C, Chang S, Colevas AD, Sunwoo JB, Maecker H, Desai M, Kohrt HE. Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy. Ann Oncol. 2017 Feb 1;28(2):415-420. doi: 10.1093/annonc/mdw570.
peripheral blood, fine needle aspiration biopsy
Dr. A. Dimitrios Colevas
Stanford University
83 participants (actual enrollment reported by the registry).
First Submitted
April 23, 2010
First Posted
May 3, 2010
Study Start
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer
Contact the study team to confirm eligibility.
Primary Completion
January 2016
Actual (reported)Study Completion
January 2016
Actual (reported)Last Updated
August 3, 2017
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: